Why AI Multiomics Will Replace Ultrasound in Liver Cancer Screening with Bharat Tewarie
In this episode of Diagnosing Dx, David Filby is joined by Bharat Tewarie, MD, MBA, CEO at Helio Genomics.
Bharat has led Helio Genomics since July 2025, bringing decades of global healthcare leadership across pharma, biotech, diagnostics, and digital health. In this conversation, we explore why liver cancer surveillance still relies too heavily on outdated imaging, why so many high-risk patients fall through the cracks, and how Helio Genomics is trying to change that with HelioLiver, its blood-based test designed to improve early detection.
We discuss the limitations of ultrasound in liver…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.